| Portfolio Companies To view the
investment structure, please click here >> 11Ants Analytics
11Ants Model Builder is a Microsoft Excel Add-In – if you can use Excel you can mine your data. Our proprietary HyperLearn technology emulates the best practices of a data mining expert, doing all the hard work for you. The technology is based on several years of research and development at New Zealand’s University of Waikato – home of one of the most respected data mining and machine learning groups in the world. To learn more visit www.11AntsAnalytics.com BioVittoria Limited
Derceto Derceto has headquarters in Auckland and San Francisco. Derceto
has the first in market "customized off-the-shelf" (COTS)
software tool which works online and in real-time to reduce the
costs of treated water distribution. Derceto optimizes pump schedules
to minimize distribution costs guided primarily by electricity tariffs.
Derceto is jointly owned by the Beca Group, Endeavour Capital and
key staff. Doctor Global Limited (Investment by Endeavour Capital) Ectus Ltd Ectus technology has application in Education, Health, Government
and Commerce.
GeoSmart GFG Group Accredited by the World Bank, GFG is acknowledged as a leader
in its field. Graftoss HTS-110 Nexus6 Limited A peak flow meter also fitted with a microcomputer measures the
patient’s lunch function. All the data is then fed into a
software programme that summarises the results. Smartinhaler®
also has an alarm to remind users to take their medication. The
Smartinhaler® has been shown in clinical trials to increase
an asthma user’s compliance. Novatein Obodies Pacific Aerospace Corporation Our holding in Pacific Aerospace Corporation was sold in October 2006. Photonic Innovations Limited Proacta Therapeutics The founding scientists, Professors Bill Denny and Bill Wilson
at the Auckland Cancer Society Research Centre, at The University
of Auckland (ACSRC), and Professors Martin Brown and Amato Giacca
at the Division of Radiation and Cancer Biology and the Department
of Radiation Oncology at Stanford University are considered world
leading authorities in the field of tumour hypoxia, a condition
that exists in a majority of solid tumours and makes treatment with
conventional chemo and radiotherapy less likely to succeed. Protemix Corporation Limited (Investment by both Endeavour Capital and Endeavour i-cap Fund) Simtrix SMX Solenza Veritide Limited The first product will be a bacterial spore detector that enables
rapid determination of whether a white powder incident is a false
alarm or a potential anthrax threat. ZyGEM
Corporation Limited (Investment by Endeavour Capital) |
People
Head
office contact details Endeavour Capital For further contact details, click here >> |
Ectus
is a company commercialising collaborative learning, video conferencing
and streaming technologies. Ectus focuses on integrating synchronous
and asynchronous collaboration technology, the theory of online
communities, learning and best practice to provide interactive,
stimulating and supportive on-line working and learning environments.
Ectus works with clients to transform face to face processes to
create effective on-line communities. 
Nexus6
was founded in 2001 to commercialise technology for the Asthma market.
Their flagship product, Smartinhaler®, is an inhaler which is
fitted with a microcomputer that records every puff of medicine
a patient takes, including details such as the date and time it
was taken. 
The Novatein technology is a process to produce compostable bioplastic resin using standard plastic
Industry plant and equipment with mechanical properties that are comparable to commodity plastics In contrast, manufacturing other bioplastics encompass highly complex and capital intensive processes. Novateins technology has very low barriers to adoption for manufacturers compared to other bioplastics. 
OBodies are naturally occurring small stable proteins that mimic antibodies. OBodies are engineered to take advantage of their unique characteristics which in many cases have advantages over the current monoclonal antibodies on the market. OBodies can be used in applications where antibodies would perform poorly, for instance where size, stability and non-refrigerated storage are important. OBodies can be used in the detection of infectious diseases in rapid diagnostics test kits for example, as a research tool within universities and contract research organisations and in the therapeutic industry. 
